Skip to main content
Equibles
GRUSF logo

GRUSF · Grown Rogue International Inc. · Metrics

Track GRUSF — free

Use GRUSF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GRUSF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.36 0.00 (-1.00%) At close · Nov 6 Play latest call Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$89.98M
Shares
249.94M
Volume · Nov 6 100 Avg daily vol (3M) 121.84K

GRUSF metrics

45 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.36
Market cap
$89.98M

Price action

23 metrics
Price change (1W)
+5.9%
Price change (30D)
-12.7%
Price change (3M)
-16.3%
Price change (6M)
-7.7%
Price change (YTD)
-30.8%
Price change (1Y)
+0.0%
Trailing year
Price change (5Y)
+260.0%
52-week high
$0.52
52-week low
$0.27
Change from 52-week high
-30.8%
Change from 52-week low
+33.3%
Annualized volatility
83.2%
Annualized volatility (3M)
61.8%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
0.4
RSI (14D)
45.0
Price vs SMA 50
-11.2%
Price vs SMA 200
-8.2%
Avg volume (3M)
124,579
Relative volume
1.2
Average dollar volume
$51,848

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
249.94M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.4×
reciprocal yield 41.9%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-12
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
43.9%
Operating margin
1.6%
Trailing 12 months
Net margin
—
Gross profit (TTM)
$16.56M
Operating profit (TTM)
$620,864
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+40.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$37.70M
Trailing 12 months
EPS growth YoY
-200.0%
Shares change YoY
-1.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+22.2%
Revenue CAGR (5Y)
+50.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
—
Debt / equity
—
Current ratio
—
EBITDA (TTM)
$1.27M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
—
Total debt
$12.73M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
$9.92M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
52 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1463000 CUSIP 39986R304 Visit website Investor relations